October 8, 2014 – Italian and Swedish researchers recently reported new information in the treatment of mesothelioma, which is an aggressive form of cancer resulting from exposure to asbestos.  By using the KB9520 molecule to activate the Estrogen Receptor Beta (ERbeta) found in the nucleus of cells, researchers discovered that mesothelioma tumor cell growth slowed […]

June 3, 2014 – Gemzar, also known as gemcitabine, is a chemotherapy drug that can slow the growth and spread of mesothelioma by interfering with the genetic material, which then kills the cell.  Gemzar has been used to treat a variety of other cancers including breast, pancreatic, ovarian and lung cancer.  High doses of Gemzar […]

April 23, 2014 – Researchers from Wayne State University School of Medicine in Detroit, Michigan, recently reported that a drug commonly used to treat the disease of alcoholism may also be effective in treating pleural mesothelioma, a malignant cancer directly related to asbestos exposure.  Disulfiram, commonly known as Antabuse, has been used in the treatment […]

March 29, 2014 – A new study examined the effectiveness of manipulating a specific molecule as a prospective treatment for mesothelioma. The study, which appeared in the journal Cell Cycle, was conducted by a group of researchers at the Sbarro Health Research Organization in Philadelphia, Pennsylvania. The researchers tested two molecules, one known as RITA, […]